Therapy for SIAD: what does the future hold?

Ther Adv Endocrinol Metab. 2023 Apr 19:14:20420188231166493. doi: 10.1177/20420188231166493. eCollection 2023.

Author

Ploutarchos Tzoulis¹

Affiliation

¹ Division of Medicine, Department of Metabolism & Experimental Therapeutics, University College London Medical School, Gower Street, London WC1E6BT, UK.

No abstract available

Keywords: SIAD; empagliflozin; hyponatraemia; sodium; tolvaptan; urea.

Publication types

Editorial